Inner Mongolia Furui Medical Science Co., Ltd. (SZSE: 300049)
Health Care · Pharmaceuticals · CN
CN¥41.67
-7.40% today · -34.1% 1Y
Inner Mongolia Furui Medical Science Co., Ltd. (SZSE: 300049) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.64B and employs 946 people.
Over the last twelve months the share price has lost 34.1%, trading between 36.50 and 90.68.
Tweenvest scores Inner Mongolia Furui Medical Science Co., Ltd. across four factors: quality 79/100, value 52/100, growth 77/100, dividend 7/100. Its strongest factor is quality.
300049 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.64B
- Revenue (TTM)
- $235.61M
- P/E
- 70.71
- EPS
- 0.59
- Dividend yield
- 0.04%
- Beta (5Y)
- -0.28
- 52-week high
- CN¥90.68
- 52-week low
- CN¥36.50
- Avg volume (3M)
- —
- Shares outstanding
- 263.99M
- Employees
- 946
- Next earnings
- —
About Inner Mongolia Furui Medical Science Co., Ltd.
Inner Mongolia Furui Medical Science Co., Ltd. functions as a dedicated platform offering specialized healthcare services. The company's primary focus lies in the liver disease sector, where it delivers a full spectrum of solutions encompassing accurate disease diagnosis, pharmaceutical treatments, and ongoing chronic condition management. Beyond this, it also provides comprehensive health management facilities and general medical care services. Established in 1998, with its headquarters situated in Beijing, China, the entity was previously known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company.
- ISIN
- CNE100000KG1
- Founded
- 1998
- Listed since
- Jan 20, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.